Back to Search Start Over

Deoxythymidylate kinase, DTYMK, is a novel gene for mitochondrial DNA depletion syndrome.

Authors :
Lam CW
Yeung WL
Ling TK
Wong KC
Law CY
Source :
Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2019 Sep; Vol. 496, pp. 93-99. Date of Electronic Publication: 2019 Jul 02.
Publication Year :
2019

Abstract

Background: Mitochondrial DNA depletion syndrome is a group of heterogeneous diseases with non-specific presentation. The common feature is the quantitative depletion of mitochondrial DNA without qualitative defects. Diagnosis of these diseases poses a challenge and whole exome sequencing is often needed for their diagnoses.<br />Case: Two siblings of a quartet family, presenting with hypotonia, microcephaly and severe intellectual disability, have been diagnosed to harbor two heterozygous variants in trans in the DTYMK gene of the thymidine biosynthesis pathway. Mitochondrial DNA depletion has been demonstrated in silico in the more severe sibling.<br />Conclusions: We suggest the consideration of incorporating DTYMK as one of the associated genes of mitochondrial DNA depletion syndrome (MDDS). DTYMK may be the missing link in the mitochondrial nucleotide salvage pathway but further characterization and additional evidence would be needed.<br /> (Copyright © 2019 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-3492
Volume :
496
Database :
MEDLINE
Journal :
Clinica chimica acta; international journal of clinical chemistry
Publication Type :
Academic Journal
Accession number :
31271740
Full Text :
https://doi.org/10.1016/j.cca.2019.06.028